How The Narrative On Evolus (EOLS) Is Resetting After Cautious 2025 And 2026 Guidance [Yahoo! Finance]
Evolus, Inc. (EOLS)
Last evolus, inc. earnings: 2/25 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
us.evolis.com/investor-relations
Company Research
Source: Yahoo! Finance
Evolus has seen its fair value estimate adjusted slightly, with the price target moving from US$15.17 to US$14.67 per share. Analysts are tying this trim to the company's preliminary 2025 net revenues landing at the low end of expectations and a cautious tone in 2026 guidance. This has led to a reset in long term outlooks and mixed reactions across the Street. As you read on, you will see how to track these shifting views and what to watch as the Evolus story develops. Stay updated as the Fair Value for Evolus shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Evolus. What Wall Street Has Been Saying ?? Bullish Takeaways Stifel trimmed its price target on Evolus to US$17 from US$20, but still highlighted the updated outlook as a reset that, in its view, clears the deck for future execution. Stifel described management's 2026 outlook as conservative and framed the guidance reset as setting the stage for s
Show less
Read more
Impact Snapshot
Event Time:
EOLS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EOLS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EOLS alerts
High impacting Evolus, Inc. news events
Weekly update
A roundup of the hottest topics
EOLS
News
- Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- Evolus Sees Toxin Market Stabilizing, Evolysse Gaining Traction, Raises 2028 Revenue Targets at Conference [Yahoo! Finance]Yahoo! Finance
- Evolus (EOLS) was downgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=EOLS&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "buy" to "hold".MarketBeat
- Jeuveau (Evolus) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]Yahoo! Finance
- AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting [Yahoo! Finance]Yahoo! Finance
EOLS
Earnings
- 3/3/26 - Beat
EOLS
Sec Filings
- 3/20/26 - Form 4
- 3/20/26 - Form 4
- 3/18/26 - Form 4
- EOLS's page on the SEC website